Important notice regarding Inveltys:
The board approved Inveltys (loteprednol etabonate ophthalmic suspension) 1% for addition to Rule 64B13-18.002. Effective August 5, 2019, Licensees are now permitted to prescribe Inveltys.
Important notice regarding Inveltys:
The board approved Inveltys (loteprednol etabonate ophthalmic suspension) 1% for addition to Rule 64B13-18.002. Effective August 5, 2019, Licensees are now permitted to prescribe Inveltys.
E-licensing demonstrates the commitment of the Department to expedite
licensure and verification processes. Learn more by clicking here! Continue reading
Click here to view a full list of bill summaries from the 2024 Florida Legislative Session that may impact your profession. Continue reading